Logo image of CTOR

CITIUS ONCOLOGY INC (CTOR) Stock Income Statement

NASDAQ:CTOR - Nasdaq - US17331Y1091 - Common Stock - Currency: USD

1.74  -0.07 (-3.87%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

 TTM
(2025-3-31)		 2024
(2024-9-30)		 2023
(2023-9-30)		 2022
(2022-9-30)
Revenue
CTOR Revenue ChartCTOR Revenue over time chart
0.000.000.000.00
Operating Expenses
CTOR Operating Expenses ChartCTOR Operating Expenses over time chart
34.17M20.57M12.12M4.86M
Research and Development
CTOR Research and Development ChartCTOR Research and Development over time chart
N/A4.92M4.24M3.43M
Selling, General, and Administrative Expenses
CTOR Selling, General, and Administrative Expenses ChartCTOR Selling, General, and Administrative Expenses over time chart
24.84M15.65M7.88M1.43M
Operating Income
CTOR Operating Income ChartCTOR Operating Income over time chart
-34.17M-20.57M-12.12M-4.86M
Income Before Taxes
CTOR Income Before Taxes ChartCTOR Income Before Taxes over time chart
-34.93M-20.57M-12.12M-4.86M
Income Tax
CTOR Income Tax ChartCTOR Income Tax over time chart
N/A576.00K576.00K576.00K
Net Income
CTOR Net Income ChartCTOR Net Income over time chart
-36.03M-21.15M-12.70M-5.43M
 
Per Share Data
EPS Diluted Total Ops
CTOR EPS Diluted Total Ops ChartCTOR EPS Diluted Total Ops over time chart
-0.48-0.31-0.18-0.08
 
Statistics

All data in USD

Charts

CTOR Income Statement data chartCTOR Revenue, Operating Income, Net Income and EBITDA ChartIncome Statements 2022 2023 2024 TTM -10M -20M -30M
CTOR Earnings Per Share (EPS) chartCTOR EPS Diluted and non-GAAP ChartEarnings Per Share 2022 2023 2024 TTM -0.1 -0.2 -0.3 -0.4